Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
7Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Exelixis, Inc. (EXEL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
15Total relationships
4Distinct source URLs
3High confidence
0.743Average confidence
2026-11-02Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Exelixis, Inc. Suppliers
Ticker
Name
Confidence
Evidence
FMCKI
Federal Home Loan Mortgage Corporation
72%
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
25 % 23 % Affiliates of McKesson Corporation 23 % 25 % Ipsen Pharma SAS 15 % 19 % Affiliates of CVS Health Corporation 13 % 13 % Cardinal Health, Inc.
FMCKI
Federal Home Loan Mortgage Corporation
72%
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten…
25 % 23 % Affiliates of McKesson Corporation 23 % 25 % Ipsen Pharma SAS 15 % 19 % Affiliates of CVS Health Corporation 13 % 13 % Cardinal Health, Inc.
TKPHF
Takeda Pharmaceutical Company Limited
72%
Contract liabilities are primarily related to deferred revenues from Ipsen Pharma SAS (Ipsen) and Takeda Pharmaceutical Company Limited (Takeda).
Exelixis, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
EXEL-DEBT
Debt stack $189.1M
90%
Market cache reports total debt of $189.1M.
EXEL-DEBT-9411
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2016-12-31.
Exelixis, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Exelixis, Inc..
Exelixis, Inc. Ownership
Holder
Name
Confidence
Evidence
EXEL-OWNER-BLACKROCK-INC
BlackRock, Inc.
90%
13F overlay lists BlackRock, Inc. as top holder; 708 tracked holders.
TKPHF
Takeda Pharmaceutical Company Limited
62%
Reverse search: TKPHF 20-F (2026-06-17) mentions 'Exelixis' in partner context. Excerpt: nd other hematological cancers. If exercised, the option would allow Takeda to license global rights to develo…
TAK
TAK
62%
Reverse search: TAK 20-F (2025-06-25) mentions 'Exelixis' in partner context. Excerpt: tinib in all territories outside of mainland China, Hong Kong, Macau, Taiwan and Russia. Crescendo Biologics U.K…